CohBar Inc
(NASDAQ : CWBR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.08%202.981.2%$406.44m
GILDGilead Sciences, Inc.
0.50%73.140.9%$396.42m
CELGCelgene Corporation
0.67%87.781.2%$341.39m
BIIBBiogen Inc.
0.25%335.251.2%$274.66m
ILMNIllumina, Inc.
1.42%352.163.5%$255.83m
REGNRegeneron Pharmaceuticals, Inc.
-0.14%385.972.6%$209.96m
EXASExact Sciences Corporation
-1.77%72.0325.3%$195.16m
VRTXVertex Pharmaceuticals Incorporated
0.59%176.831.9%$160.81m
SRPTSarepta Therapeutics, Inc.
0.93%153.7616.4%$126.02m
AAgilent Technologies, Inc.
-0.51%68.731.5%$120.88m
ALXNAlexion Pharmaceuticals, Inc.
1.51%119.592.0%$109.12m
NKTRNektar Therapeutics
0.57%58.645.6%$96.51m
ALNYAlnylam Pharmaceuticals, Inc
0.42%93.759.7%$96.22m
BMRNBioMarin Pharmaceutical Inc.
1.00%99.134.4%$91.59m
INCYIncyte Corporation
0.73%67.512.5%$88.35m

Company Profile

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.